Merck to produce Johnson & Johnson COVID-19 vaccine
WASHINGTON — Merck will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House reported Tuesday. This announcement comes as the White House looks to ramp up the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine